Terug
Dagbereik
€ 29,00
€ 29,50
52-Weeksbereik
€ 19,44
€ 42,81
Volume
1.129
50D / 200D Gem.
€ 33,36
/
€ 35,01
Vorige Slotkoers
€ 29,49
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 536,1 | 0,3 |
| P/B | 17,0 | 2,9 |
| ROE % | 3,4 | 3,7 |
| Net Margin % | 1,8 | 3,8 |
| Rev Growth 5Y % | 72,2 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,00
€ 0,00 – € 0,00
|
350 M | 0 |
| FY2029 |
€ 0,00
€ 0,00 – € 0,00
|
300 M | 0 |
| FY2028 |
€ 1,21
€ 1,11 – € 1,30
|
250 M | 1 |
Belangrijkste Punten
Revenue grew 72,16% annually over 5 years — strong growth
ROE of 3,37% is below average
Debt/Equity of 0,06 — conservative balance sheet
Negative free cash flow of -2,40M
P/E of 536,05 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 11,54%
Groei
Revenue Growth (5Y)
72,16%
Revenue (1Y)60,62%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
3,37%
ROIC7,75%
Net Margin1,75%
Op. Margin6,04%
Veiligheid
Debt / Equity
0,06
Current Ratio1,96
Interest Coverage24,04
Waardering
P/E Ratio
536,05
P/B Ratio16,97
EV/EBITDA153,39
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60,62% | Revenue Growth (3Y) | 90,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 72,16% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 121,36M | Net Income (TTM) | 2,12M |
| ROE | 3,37% | ROA | 1,98% |
| Gross Margin | 86,39% | Operating Margin | 6,04% |
| Net Margin | 1,75% | Free Cash Flow (TTM) | -2,40M |
| ROIC | 7,75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 1,96 |
| Interest Coverage | 24,04 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 536,05 | P/B Ratio | 16,97 |
| P/S Ratio | 9,36 | PEG Ratio | -3,55 |
| EV/EBITDA | 153,39 | Dividend Yield | 0,00% |
| Market Cap | 1,14B | Enterprise Value | 1,12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 121,36M | 75,56M | 33,56M | 17,99M | 13,82M |
| Net Income | 2,12M | -3,72M | -13,73M | -14,60M | -7,54M |
| EPS (Diluted) | 0,05 | -0,10 | -0,38 | -0,43 | -0,23 |
| Gross Profit | 104,84M | 62,03M | 28,47M | 10,77M | 10,07M |
| Operating Income | 7,33M | -5,00M | -13,19M | -13,45M | -8,77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 107,26M | 84,54M | 71,46M | 82,95M | 91,34M |
| Total Liabilities | 40,30M | 25,79M | 14,75M | 14,09M | 14,36M |
| Shareholders' Equity | 66,96M | 58,75M | 56,71M | 68,86M | 76,98M |
| Total Debt | 3,94M | 1,79M | 2,14M | 1,91M | 2,15M |
| Cash & Equivalents | 15,67M | 17,46M | 14,21M | 24,07M | 28,62M |
| Current Assets | 65,52M | 44,75M | 27,19M | 31,39M | 32,89M |
| Current Liabilities | 33,40M | 20,90M | 13,19M | 12,59M | 11,29M |